Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Statins reduce pneumonia death risk

  • Comment
Patients who take statins before being hospitalised with pneumonia are less likely to die of pneumonia within 90 days, a study has shown.

Danish researchers reviewed data from 29,900 adults hospitalised between 1997 and 2004 and found the 90-day death rate among 1,371 patients taking statins was 16.8%, compared with 22.4% who were not taking the drugs.

Report author Reimar W Thomsen said: 'Given the availability of statins, with their relatively low cost and mild adverse effects, positive results of statin therapy trials in patients with pneumonia would have substantial clinical and public health implications.'

Archives of Internal Medicine (2008) 168: 2081-2087

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs